Delivery Order SPE2DB22D1106-SPE2DB25FEHC3

Award Date 4/9/25
Potential Completion Date 4/10/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,557,747 units of 20 mg Sumatriptan nasal sprays. The delivery order, valued at $2,404.95, is part of an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which is a larger contract vehicle valued at $999,999,999 and runs through November 2026. This IDC enables efficient government...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,567,692,724 units of Sumatriptan 20 mg nasal sprays. The $1,566.49 firm fixed-price contract was awarded on March 25, 2025 by the Defense Logistics Agency (DLA), with a period of performance ending on March 26, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,250,728 units of 20 mg sumatriptan nasal sprays. The contract has a ceiling value of $7,496.66 and a period of performance through May 15, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,565,827,998 units of Sumatriptan 20 mg nasal sprays. The firm-fixed-price delivery order contract has a ceiling value of $2,296.90 and an ultimate completion date of September 17, 2024. This award is not designated as a set-aside contract. Additionally, Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,296,703 units of Sumatriptan 20 mg nasal sprays. The contract is a firm-fixed price delivery order with a ceiling value of $1,863.38 and a period of performance through July 31, 2024. This award is not associated with a set-aside program. Amerisourcebergen has been awarded numerous federal contracts by various defense and civilian...
This is a federal delivery order award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Sumatriptan 20 mg nasal sprays. The firm-fixed-price delivery order, valued at $1,214.17, has an ultimate completion date of August 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $27,364.23 to Amerisourcebergen Drug Corporation for the supply of 4,565,804,624 units of Sumatriptan 20 mg nasal sprays. The contract has an ultimate completion date of September 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, is fulfilling this order as part of the company's indefinite delivery contract with the DLA Troop Support Medical valued up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,804,778 units of Sumatriptan 20 mg nasal sprays. The firm-fixed-price contract has a ceiling value of $2,055.07 and is set to expire on September 16, 2024. The contract is not associated with a set-aside program. Amerisourcebergen holds several indefinite delivery contracts (IDCs) with the DLA Troop Support Medical, valued...
The Defense Logistics Agency (DLA) awarded a $1,149.57 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,534,184 units of sumatriptan 20 mg nasal sprays. This delivery order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has an ultimate...
This federal contract award, valued at $1,652.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,567,925,281 units of Sumatriptan 5 mg nasal sprays, a medication used to treat migraines. The contract has a firm fixed-price, delivery order type, with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEHC3
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,860,636 units of Sumatriptan 20 mg nasal sprays. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,822.03 and a completion date of April 10, 2025. AmerisourceBergen, a for-profit organization, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for this award. The contract does not have a set-aside designation, indicating open competition. This award supports the DLA's procurement of essential pharmaceutical products for military healthcare programs.

Generated 7/9/25, 9:58 AM